TY  - GEN
AU  - Yokota,Masako
AU  - Kobayashi,Yukiho
AU  - Morita,Jumpei
AU  - Suzuki,Hiroyuki
AU  - Hashimoto,Yoshihide
AU  - Sasaki,Yoshihiro
AU  - Akiyoshi,Kazunari
AU  - Moriyama,Keiji
TI  - Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis
SN  - 1932-6203
PY  - 2015///0330
KW  - Acrocephalosyndactylia
KW  - genetics
KW  - Amino Acid Substitution
KW  - Animals
KW  - Calcification, Physiologic
KW  - drug effects
KW  - Cell Differentiation
KW  - Cell Line
KW  - Codon
KW  - Cranial Sutures
KW  - abnormalities
KW  - Disease Models, Animal
KW  - Drug Delivery Systems
KW  - Female
KW  - Fibroblast Growth Factor 10
KW  - Fibroblast Growth Factor 2
KW  - metabolism
KW  - Gene Expression
KW  - Male
KW  - Mice
KW  - Mice, Transgenic
KW  - Mutation
KW  - Nanogels
KW  - Osteoblasts
KW  - cytology
KW  - Phenotype
KW  - Polyethylene Glycols
KW  - administration & dosage
KW  - Polyethyleneimine
KW  - Protein Binding
KW  - RNA-Binding Proteins
KW  - Receptor, Fibroblast Growth Factor, Type 2
KW  - Recombinant Proteins
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0101693
ER  -